Table of Contents Executive Summary 1 Industry Overview of Generic Active Pharmaceutical Ingredients 1.1 Definition of Generic Active Pharmaceutical Ingredients 1.2 Generic Active Pharmaceutical Ingredients Segment by Type 1.2.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Monoclonal Antibodies 1.2.3 Hormones 1.2.4 Cytokines 1.2.5 Fusion Proteins 1.2.6 Therapeutic Enzymes 1.2.7 Vaccines 1.2.8 Blood Factors 1.3 Generic Active Pharmaceutical Ingredients Segment by Applications 1.3.1 Global Generic Active Pharmaceutical Ingredients Consumption Comparison by Applications (2014-2025) 1.3.2 Oncology 1.3.3 Diabetes 1.3.4 Cardiovascular Disease 1.3.5 CNS and Neurological Disorders 1.3.6 Endocrinology 1.3.7 Others 1.4 Global Generic Active Pharmaceutical Ingredients Overall Market 1.4.1 Global Generic Active Pharmaceutical Ingredients Revenue (2014-2025) 1.4.2 Global Generic Active Pharmaceutical Ingredients Production (2014-2025) 1.4.3 North America Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025) 1.4.4 Europe Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025) 1.4.5 China Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025) 1.4.6 Japan Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025) 1.4.7 Southeast Asia Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025) 1.4.8 India Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Generic Active Pharmaceutical Ingredients 2.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients 2.4 Industry Chain Structure of Generic Active Pharmaceutical Ingredients 3 Development and Manufacturing Plants Analysis of Generic Active Pharmaceutical Ingredients 3.1 Capacity and Commercial Production Date 3.2 Global Generic Active Pharmaceutical Ingredients Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Generic Active Pharmaceutical Ingredients 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Generic Active Pharmaceutical Ingredients Production and Capacity Analysis 4.2 Generic Active Pharmaceutical Ingredients Revenue Analysis 4.3 Generic Active Pharmaceutical Ingredients Price Analysis 4.4 Market Concentration Degree 5 Generic Active Pharmaceutical Ingredients Regional Market Analysis 5.1 Generic Active Pharmaceutical Ingredients Production by Regions 5.1.1 Global Generic Active Pharmaceutical Ingredients Production by Regions 5.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Regions 5.2 Generic Active Pharmaceutical Ingredients Consumption by Regions 5.3 North America Generic Active Pharmaceutical Ingredients Market Analysis 5.3.1 North America Generic Active Pharmaceutical Ingredients Production 5.3.2 North America Generic Active Pharmaceutical Ingredients Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Generic Active Pharmaceutical Ingredients Import and Export 5.4 Europe Generic Active Pharmaceutical Ingredients Market Analysis 5.4.1 Europe Generic Active Pharmaceutical Ingredients Production 5.4.2 Europe Generic Active Pharmaceutical Ingredients Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Generic Active Pharmaceutical Ingredients Import and Export 5.5 China Generic Active Pharmaceutical Ingredients Market Analysis 5.5.1 China Generic Active Pharmaceutical Ingredients Production 5.5.2 China Generic Active Pharmaceutical Ingredients Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Generic Active Pharmaceutical Ingredients Import and Export 5.6 Japan Generic Active Pharmaceutical Ingredients Market Analysis 5.6.1 Japan Generic Active Pharmaceutical Ingredients Production 5.6.2 Japan Generic Active Pharmaceutical Ingredients Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Generic Active Pharmaceutical Ingredients Import and Export 5.7 Southeast Asia Generic Active Pharmaceutical Ingredients Market Analysis 5.7.1 Southeast Asia Generic Active Pharmaceutical Ingredients Production 5.7.2 Southeast Asia Generic Active Pharmaceutical Ingredients Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Generic Active Pharmaceutical Ingredients Import and Export 5.8 India Generic Active Pharmaceutical Ingredients Market Analysis 5.8.1 India Generic Active Pharmaceutical Ingredients Production 5.8.2 India Generic Active Pharmaceutical Ingredients Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Generic Active Pharmaceutical Ingredients Import and Export 6 Generic Active Pharmaceutical Ingredients Segment Market Analysis (by Type) 6.1 Global Generic Active Pharmaceutical Ingredients Production by Type 6.2 Global Generic Active Pharmaceutical Ingredients Revenue by Type 6.3 Generic Active Pharmaceutical Ingredients Price by Type 7 Generic Active Pharmaceutical Ingredients Segment Market Analysis (by Application) 7.1 Global Generic Active Pharmaceutical Ingredients Consumption by Application 7.2 Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019) 8 Generic Active Pharmaceutical Ingredients Major Manufacturers Analysis 8.1 Pfizer, Inc. (U.S.) 8.1.1 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.1.2 Pfizer, Inc. (U.S.) Product Introduction, Application and Specification 8.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Novartis International AG (Switzerland) 8.2.1 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.2.2 Novartis International AG (Switzerland) Product Introduction, Application and Specification 8.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Sanofi (France) 8.3.1 Sanofi (France) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.3.2 Sanofi (France) Product Introduction, Application and Specification 8.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Boehringer Ingelheim (Germany) 8.4.1 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.4.2 Boehringer Ingelheim (Germany) Product Introduction, Application and Specification 8.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Bristol-Myers Squibb (U.S.) 8.5.1 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.5.2 Bristol-Myers Squibb (U.S.) Product Introduction, Application and Specification 8.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Teva Pharmaceutical Industries Ltd. (Israel) 8.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Product Introduction, Application and Specification 8.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Eli Lilly and Company (U.S.) 8.7.1 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.7.2 Eli Lilly and Company (U.S.) Product Introduction, Application and Specification 8.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 GlaxoSmithKline plc (U.K.) 8.8.1 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.8.2 GlaxoSmithKline plc (U.K.) Product Introduction, Application and Specification 8.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Merck & Co., Inc. (U.S.) 8.9.1 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.9.2 Merck & Co., Inc. (U.S.) Product Introduction, Application and Specification 8.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 AbbVie Inc. (U.S.) 8.10.1 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served 8.10.2 AbbVie Inc. (U.S.) Product Introduction, Application and Specification 8.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 9 Development Trend of Analysis of Generic Active Pharmaceutical Ingredients Market 9.1 Global Generic Active Pharmaceutical Ingredients Market Trend Analysis 9.1.1 Global Generic Active Pharmaceutical Ingredients Market Size (Volume and Value) Forecast 2019-2025 9.2 Generic Active Pharmaceutical Ingredients Regional Market Trend 9.2.1 North America Generic Active Pharmaceutical Ingredients Forecast 2019-2025 9.2.2 Europe Generic Active Pharmaceutical Ingredients Forecast 2019-2025 9.2.3 China Generic Active Pharmaceutical Ingredients Forecast 2019-2025 9.2.4 Japan Generic Active Pharmaceutical Ingredients Forecast 2019-2025 9.2.5 Southeast Asia Generic Active Pharmaceutical Ingredients Forecast 2019-2025 9.2.6 India Generic Active Pharmaceutical Ingredients Forecast 2019-2025 9.3 Generic Active Pharmaceutical Ingredients Market Trend (Product Type) 9.4 Generic Active Pharmaceutical Ingredients Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Generic Active Pharmaceutical Ingredients Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Generic Active Pharmaceutical Ingredients Table Global Generic Active Pharmaceutical Ingredients Production (K MT) Growth Rate Comparison by Types (2014-2025) Figure Global Generic Active Pharmaceutical Ingredients Production Market Share by Types in 2018 Figure Monoclonal Antibodies Product Picture Figure Hormones Product Picture Figure Cytokines Product Picture Figure Fusion Proteins Product Picture Figure Therapeutic Enzymes Product Picture Figure Vaccines Product Picture Figure Blood Factors Product Picture Table Global Generic Active Pharmaceutical Ingredients Consumption (K MT) Comparison by Applications (2014-2025) Figure Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Applications in 2018 Figure Oncology Figure Diabetes Figure Cardiovascular Disease Figure CNS and Neurological Disorders Figure Endocrinology Figure Others Figure Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) (2014-2025) Figure Global Generic Active Pharmaceutical Ingredients Production (K MT) (2014-2025) Figure North America Generic Active Pharmaceutical Ingredients Market Size (Million USD) (2014-2025) Figure Europe Generic Active Pharmaceutical Ingredients Market Size (Million USD) (2014-2025) Figure China Generic Active Pharmaceutical Ingredients Market Size (Million USD) (2014-2025) Figure Japan Generic Active Pharmaceutical Ingredients Market Size (Million USD) (2014-2025) Figure Southeast Asia Generic Active Pharmaceutical Ingredients Market Size (Million USD) (2014-2025) Figure India Generic Active Pharmaceutical Ingredients Market Size (Million USD) (2014-2025) Table Generic Active Pharmaceutical Ingredients Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Generic Active Pharmaceutical Ingredients in 2018 Figure Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients Figure Industry Chain Structure of Generic Active Pharmaceutical Ingredients Table Capacity and Commercial Production Date of Key Manufacturers Table Global Generic Active Pharmaceutical Ingredients Manufacturing Plants Distribution Table Generic Active Pharmaceutical Ingredients Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Generic Active Pharmaceutical Ingredients Capacity (K MT) of Major Manufacturers (2014-2019) Table Generic Active Pharmaceutical Ingredients Production (K MT) of Major Manufacturers (2014-2019) Table Generic Active Pharmaceutical Ingredients Production Market Share of Major Manufacturers (2014-2019) Figure Generic Active Pharmaceutical Ingredients Production Share by Manufacturers in 2018 Table Generic Active Pharmaceutical Ingredients Revenue (Million US$) of Major Manufacturers (2014-2019) Table Generic Active Pharmaceutical Ingredients Revenue Market Share of Major Manufacturers (2014-2019) Figure Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers in 2018 Table Generic Active Pharmaceutical Ingredients Average Price (USD/MT) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Generic Active Pharmaceutical Ingredients Production by Regions 2014-2019 (K MT) Table Global Generic Active Pharmaceutical Ingredients Production Market Share by Regions 2014-2019 Figure Global Generic Active Pharmaceutical Ingredients Production Market Share by Regions in 2018 Table Global Generic Active Pharmaceutical Ingredients Revenue by Regions 2014-2019 (Million USD) Table Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions 2014-2019 Figure Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions in 2018 Table Global Generic Active Pharmaceutical Ingredients Consumption by Regions 2014-2019 (K MT) Table Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Regions 2014-2019 Figure North America Generic Active Pharmaceutical Ingredients Production Growth Rate 2014-2019 (K MT) Figure North America Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million USD) Table North America Generic Active Pharmaceutical Ingredients Production, Consumption Import and Export (K MT) Figure Europe Generic Active Pharmaceutical Ingredients Production Growth Rate 2014-2019 (K MT) Figure Europe Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million USD) Table Europe Generic Active Pharmaceutical Ingredients Production, Consumption Import and Export (K MT) Figure China Generic Active Pharmaceutical Ingredients Production Growth Rate 2014-2019 (K MT) Figure China Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million USD) Table China Generic Active Pharmaceutical Ingredients Production, Consumption Import and Export (K MT) Figure Japan Generic Active Pharmaceutical Ingredients Production Growth Rate 2014-2019 (K MT) Figure Japan Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million USD) Table Japan Generic Active Pharmaceutical Ingredients Production, Consumption Import and Export (K MT) Figure Southeast Asia Generic Active Pharmaceutical Ingredients Production Growth Rate 2014-2019 (K MT) Figure Southeast Asia Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Generic Active Pharmaceutical Ingredients Production, Consumption Import and Export (K MT) Figure India Generic Active Pharmaceutical Ingredients Production Growth Rate 2014-2019 (K MT) Figure India Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million USD) Table India Generic Active Pharmaceutical Ingredients Production, Consumption Import and Export (K MT) Figure Global Consumption Generic Active Pharmaceutical Ingredients Market Share by Application (2014-2019) Figure Global Value (Consumption) Generic Active Pharmaceutical Ingredients Market Share by Application (2014-2019) Table Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Sanofi (France) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Sanofi (France) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Sanofi (France) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Sanofi (France) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Sanofi (France) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Sanofi (France) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Sanofi (France) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Table AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served Table AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification Table AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019) Table AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Market Share (2014-2019) Figure AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Revenue Market Share (2014-2019) Table AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Main Business and Markets Served Figure Global Generic Active Pharmaceutical Ingredients Production (K MT) Growth Rate Forecast 2019-2025 Figure Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Generic Active Pharmaceutical Ingredients Sales Price (USD/MT) Forecast 2019-2025 Figure North America Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast 2019-2025 (K MT) Figure North America Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast 2019-2025 (K MT) Figure Europe Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast 2019-2025 (K MT) Figure China Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast 2019-2025 (K MT) Figure Japan Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast 2019-2025 (K MT) Figure Southeast Asia Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast 2019-2025 (K MT) Figure India Generic Active Pharmaceutical Ingredients Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K MT) of Generic Active Pharmaceutical Ingredients by Type (2019-2025) Table Global Consumption (K MT) of Generic Active Pharmaceutical Ingredients by Application (2019-2025) Table Generic Active Pharmaceutical Ingredients Distributors List Table Generic Active Pharmaceutical Ingredients Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer, Inc. (U.S.) Novartis International AG (Switzerland) Sanofi (France) Boehringer Ingelheim (Germany) Bristol-Myers Squibb (U.S.) Teva Pharmaceutical Industries Ltd. (Israel) Eli Lilly and Company (U.S.) GlaxoSmithKline plc (U.K.) Merck & Co., Inc. (U.S.) AbbVie Inc. (U.S.)